- Home
- MREO vs LPA Comparison
MREO vs LPA Comparison
Compare MREO & LPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MREO | LPA |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.5M | 79.0M |
| IPO Year | 2017 | 2023 |
Fundamental Metrics
Financial Performance| Metric | MREO | LPA |
|---|---|---|
| Price | $0.35 | $2.87 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $3.13 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 11.4K |
| Earning Date | 03-19-2026 | 03-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $500,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6,363.05 | N/A |
| P/E Ratio | ★ N/A | $11.25 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.20 | $2.04 |
| 52 Week High | $2.94 | $9.71 |
Technical Indicators
Market Signals| Indicator | MREO | LPA |
|---|---|---|
| Relative Strength Index (RSI) | 34.82 | 61.01 |
| Support Level | $0.20 | $2.51 |
| Resistance Level | $0.42 | $2.94 |
| Average True Range (ATR) | 0.03 | 0.14 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 22.62 | 79.25 |
Price Performance
Historical ComparisonAbout MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About LPA Logistic Properties of the Americas
Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns, and manages a diversified portfolio of warehouse logistics assets in Central America and South America. It focuses on modern Class A logistics real estate in high-growth and high-barrier-to-entry markets that are undersupplied and have low penetration rates. The company has three operating segments, based on geographic regions, consisting of Colombia, Peru, and Costa Rica. The company generates the majority of its revenue from the Costa Rica geographical segment.